CRISM Therapeutics (CRTX) Stock Chart & Stock Price History GBX 10.50 +1.25 (+13.51%) As of 10:46 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsBuy This Stock CRISM Therapeutics Stock Price Performance The CRISM Therapeutics (CRTX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 5.00%. In the past month, the stock has increased 5.00%, reflecting recent market activity. As of the latest close, CRISM Therapeutics traded at GBX 10.20 with a market cap of £4.08 million and volume of 40,466 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+21.25%1 Month Performance+5.00%3 Month Performance-52.49%Year-To-Date Performance+5.00% CRTX Stock Chart for Wednesday, September, 17, 2025 CRTX Chart by TradingView CRISM Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/16/2025GBX 10.50GBX 10.20-2.86%GBX 10.50GBX 940,466 shs£4.08 million09/15/2025GBX 8.66GBX 10.50+21.25%GBX 10.50GBX 899,479 shs£4.20 million09/12/2025GBX 8.78GBX 8.66-1.37%GBX 9GBX 8651,310 shs£3.46 million09/11/2025GBX 9.74GBX 8.78-9.86%GBX 9.50GBX 8.7890,575 shs£3.51 million09/10/2025GBX 10GBX 9.74-2.60%GBX 10.38GBX 9.50172,444 shs£3.89 million09/09/2025GBX 10.10GBX 10-0.99%GBX 10.50GBX 1016,447 shs£4.00 million09/08/2025GBX 10.10GBX 10.10GBX 11GBX 10.1040,897 shs£4.04 million09/05/2025GBX 10.13GBX 10.10-0.30%GBX 10.10GBX 1018,928 shs£4.04 million09/04/2025GBX 10.13GBX 10.13GBX 11GBX 10.1313,662 shs£4.05 million09/03/2025GBX 10.89GBX 10.13-6.98%GBX 11GBX 10.1356,289 shs£4.05 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/02/2025GBX 10.21GBX 10.89+6.66%GBX 11.50GBX 10.13262,443 shs£4.35 million09/01/2025GBX 10.15GBX 10.21+0.59%GBX 11.50GBX 10318,338 shs£4.08 million08/29/2025GBX 10.84GBX 10.15-6.37%GBX 10.84GBX 10.15110,781 shs£1.11 million08/28/2025GBX 10.84GBX 10.84GBX 10.84GBX 10.3620,640 shs£1.18 million08/27/2025GBX 10.30GBX 10.84+5.24%GBX 10.90GBX 10.8426,942 shs£1.18 million08/26/2025GBX 10.30GBX 10.30GBX 11GBX 1086,996 shs£1.12 million08/25/2025GBX 10.30GBX 10.30GBX 11GBX 10403,868 shs£1.12 million08/22/2025GBX 10.23GBX 10.30+0.68%GBX 11GBX 10403,868 shs£1.12 million08/21/2025GBX 10.42GBX 10.23-1.78%GBX 10.90GBX 10.15108,084 shs£1.11 million08/20/2025GBX 10GBX 10.42+4.15%GBX 10.50GBX 10233,019 shs£1.14 million08/19/2025GBX 10GBX 10GBX 10.50GBX 101,653 shs£1.09 million08/18/2025GBX 10GBX 10GBX 11GBX 1014,173 shs£1.09 million Related Companies Celsius Resources Stock Price Chart Artemis Resources Stock Price Chart Galileo Resources Stock Price Chart Bluebird Merchant Ventures Stock Price Chart Bezant Resources Stock Price Chart Tirupati Graphite Stock Price Chart Critical Metals Stock Price Chart Firering Strategic Minerals Stock Price Chart Cadence Minerals Stock Price Chart Cloudbreak Discovery Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CRTX) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
